Pharmaceutical manufacturer and nutraceutical producer serving Brazilian healthcare market
Althaia manufactures pharmaceuticals and nutraceuticals for the Brazilian market, operating an R&D center on-site and managing regulatory compliance as a core operational constraint. The hiring mix—dominated by marketing (4 roles) and manufacturing (3 roles) with accelerating velocity—signals active channel expansion and production scaling. Current projects cluster around sell-out campaigns, trade marketing customization, and pilot batch production, while pain points center on packaging compliance and regulatory documentation management.
Althaia is a privately held pharmaceutical manufacturer founded in 2010, headquartered in Atibaia, São Paulo. The company develops, manufactures, and distributes pharmaceutical products under the Althaia brand and nutraceuticals through its subsidiary Equaliv. Operations include an in-house R&D center, manufacturing facilities, and a regulatory compliance function managing Brazilian market submissions. The company serves healthcare professionals and end-market channels through trade marketing and direct sales.
Althaia uses SAP, TOTVS, and ADP for enterprise operations; Power BI for analytics; WMS for warehouse management; HPLC and Agilent for quality control; SuccessFactors for HR; and standard collaboration tools (Zoom, Google Meet, WhatsApp Business).
Current priorities include sell-out and sales incentive campaigns, customized trade marketing for channel partners, merchandising and point-of-sale tools, pilot batch production, and ANVISA regulatory documentation submission.
Althaia S.A. Indústria Farmacêutica's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.